Literature DB >> 35943704

Prefrontal cortical circuits in anxiety and fear: an overview.

Yihua Chen1, Nengyuan Hu2, Jianming Yang2, Tianming Gao3.   

Abstract

Pathological anxiety is among the most difficult neuropsychiatric diseases to treat pharmacologically, and it represents a major societal problem. Studies have implicated structural changes within the prefrontal cortex (PFC) and functional changes in the communication of the PFC with distal brain structures in anxiety disorders. Treatments that affect the activity of the PFC, including cognitive therapies and transcranial magnetic stimulation, reverse anxiety- and fear-associated circuit abnormalities through mechanisms that remain largely unclear. While the subjective experience of a rodent cannot be precisely determined, rodent models hold great promise in dissecting well-conserved circuits. Newly developed genetic and viral tools and optogenetic and chemogenetic techniques have revealed the intricacies of neural circuits underlying anxiety and fear by allowing direct examination of hypotheses drawn from existing psychological concepts. This review focuses on studies that have used these circuit-based approaches to gain a more detailed, more comprehensive, and more integrated view on how the PFC governs anxiety and fear and orchestrates adaptive defensive behaviors to hopefully provide a roadmap for the future development of therapies for pathological anxiety.
© 2022. Higher Education Press.

Entities:  

Keywords:  DREADD; anxiety; fear; neural circuits; optogenetics; prefrontal cortex

Mesh:

Year:  2022        PMID: 35943704     DOI: 10.1007/s11684-022-0941-2

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   9.927


  155 in total

1.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 2.  Efficacy of treatments for anxiety disorders: a meta-analysis.

Authors:  Borwin Bandelow; Markus Reitt; Christian Röver; Sophie Michaelis; Yvonne Görlich; Dirk Wedekind
Journal:  Int Clin Psychopharmacol       Date:  2015-07       Impact factor: 1.659

3.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 4.  The size and burden of mental disorders and other disorders of the brain in Europe 2010.

Authors:  H U Wittchen; F Jacobi; J Rehm; A Gustavsson; M Svensson; B Jönsson; J Olesen; C Allgulander; J Alonso; C Faravelli; L Fratiglioni; P Jennum; R Lieb; A Maercker; J van Os; M Preisig; L Salvador-Carulla; R Simon; H-C Steinhausen
Journal:  Eur Neuropsychopharmacol       Date:  2011-09       Impact factor: 4.600

5.  Widespread underrecognition and undertreatment of anxiety and mood disorders: results from 3 European studies.

Authors:  Yves Lecrubier
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

Review 6.  Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.

Authors:  Michael Davis; David L Walker; Leigh Miles; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

7.  Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States.

Authors:  Ronald C Kessler; Maria Petukhova; Nancy A Sampson; Alan M Zaslavsky; Hans-Ullrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2012-08-01       Impact factor: 4.035

Review 8.  Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective.

Authors:  Dan W Grupe; Jack B Nitschke
Journal:  Nat Rev Neurosci       Date:  2013-07       Impact factor: 34.870

9.  Scaling-up treatment of depression and anxiety: a global return on investment analysis.

Authors:  Dan Chisholm; Kim Sweeny; Peter Sheehan; Bruce Rasmussen; Filip Smit; Pim Cuijpers; Shekhar Saxena
Journal:  Lancet Psychiatry       Date:  2016-04-12       Impact factor: 27.083

Review 10.  Treatment of anxiety disorders.

Authors:  Borwin Bandelow; Sophie Michaelis; Dirk Wedekind
Journal:  Dialogues Clin Neurosci       Date:  2017-06       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.